Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.

Clin Chest Med

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Published: June 2013

Tuberculosis (TB) is the leading cause of opportunistic infection and mortality among HIV-infected persons. Screening for symptoms of TB in people with HIV infection, use of isoniazid preventive therapy for those with latent TB infection, earlier diagnosis and treatment of active TB disease, and early initiation of antiretroviral therapy are essential for controlling the spread of TB. Treatment of HIV-related TB is complicated by overlapping drug toxicities and drug-drug interactions between antiretroviral therapy and anti-TB therapy and risk for development of immune reconstitution inflammatory disease. This review provides an overview of the prevention and treatment of TB in HIV-infected persons.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746796PMC
http://dx.doi.org/10.1016/j.ccm.2013.02.003DOI Listing

Publication Analysis

Top Keywords

prevention treatment
8
hiv-infected persons
8
antiretroviral therapy
8
human immunodeficiency
4
immunodeficiency virus-associated
4
virus-associated tuberculosis
4
tuberculosis update
4
update prevention
4
treatment
4
treatment tuberculosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!